Let's face it the very positive if our so called management team start to sell the story right.
They could also use it to Improve future Zolpimist deals, and maybe use this to press Teva to push harder to get their MAA approved.
It could also help our partners with commercialisation once approvals are done
Ann: ZolpiMist Clinical Results Published, page-27
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $163.0M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.8¢ | 15.0¢ | $198.5K | 1.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 438029 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 283200 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |